|
Market Closed -
Swiss Exchange
18:30:11 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 127.90 CHF | -1.05% |
|
+2.65% | +16.53% |
| 10-25 | Novartis Reports Positive Results from Late-stage Studies for Remibrutinib | MT |
| 10-24 | Novartis AG - Special Call |
| Market Cap | 295B 263B 243B 221B 413B 27,996B 419B 2,922B 1,156B 14,662B 1,107B 1,083B 46,261B | P/E 2026 * |
21.8x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 327B 291B 269B 244B 458B 31,000B 464B 3,236B 1,280B 16,236B 1,226B 1,199B 51,224B | EV / Sales 2026 * |
5.68x | EV / Sales 2027 * | 5.27x |
| Free-Float |
91.66% | Yield 2026 * |
2.81% | Yield 2027 * | 2.94% |
Last Transcript: Novartis AG
| 1 day | -1.05% | ||
| 1 week | +2.65% | ||
| Current month | +5.81% | ||
| 1 month | +7.03% | ||
| 3 months | +0.55% | ||
| 6 months | +12.35% | ||
| Current year | +16.53% |
| 1 week | 123.88 |  | 129.34 |
| 1 month | 116.12 | | 129.34 |
| Current year | 107.88 | | 132.82 |
| 1 year | 97.18 | | 132.82 |
| 3 years | 81.55 | | 132.82 |
| 5 years | 73.14 | | 132.82 |
| 10 years | 68.07 | | 132.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +2.65% | - | - | 295B | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.09% | +2.17% | +37.02% | +69.16% | 444.85B | |
| Weighted average by Cap. | -1.33% | +2.66% | +41.02% | +79.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.49B 51.3B 47.43B 43B 80.58B 5,458B 81.67B 570B 225B 2,858B 216B 211B 9,019B | 61.39B 54.77B 50.65B 45.91B 86.04B 5,828B 87.21B 608B 241B 3,052B 230B 225B 9,630B |
| Net income | 14.3B 12.76B 11.8B 10.7B 20.05B 1,358B 20.32B 142B 56.08B 711B 53.69B 52.53B 2,244B | 15.94B 14.23B 13.15B 11.92B 22.35B 1,514B 22.65B 158B 62.51B 793B 59.84B 58.56B 2,501B |
| Net Debt | 31.64B 28.23B 26.1B 23.66B 44.35B 3,004B 44.95B 314B 124B 1,573B 119B 116B 4,963B | 28.7B 25.61B 23.68B 21.46B 40.22B 2,724B 40.77B 284B 113B 1,427B 108B 105B 4,502B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | CHF 127.90 | -1.05% | 400,000 |
| 22/10/26 | CHF 129.26 | +1.62% | 400,000 |
| 21/10/26 | CHF 127.20 | +0.70% | 400,000 |
| 20/10/26 | CHF 126.32 | +1.64% | 400,000 |
| 19/10/26 | CHF 124.28 | -0.26% | 400,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NOVNEE Stock
Select your edition
All financial news and data tailored to specific country editions
